Sarah B. Goldberg, Balazs Halmos, Narjust Florez, Wade Thomas Iams, Kartik Konduri, Xiuning Le, Danny Nguyen, Luis E. Raez, Jonathan W. Riess, Joshua K. Sabari, Janet Chen Tu, Dave Bjork, Nichelle Stigger, Shiven B. Patel, Annika Hulten, Karen Xia, Paul Cifuentes, Farah Shanoon, Illse Leipoldt, Ticiana Leal. "COPERNICUS, a pragmatic phase 2b study of first-line (1L) subcutaneous (SC) amivantamab (ami) + lazertinib (laz) with supportive care in
                    <i>EGFR</i>
                    -mutated advanced NSCLC: Early safety results.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8613